Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...
Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...
Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...
Intel Corporation (NASDAQ:INTC) Q4 2025 Earnings Call Transcript January 22, 2026 Intel Corporation beats earnings ...
Explore how real estate tokenization works through smart contract architecture, enabling secure, transparent property ...
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...
Tuesday, January 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc.
The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in more than 55 early-stage AI companies, in partnership with Inovia Capital ...
A new study by researchers in Japan offers new insights into how protocells may have inherited and enriched genetic material before modern biology emerged. By exposing mixed phospholipid vesicles to ...
Modern cells are complex chemical entities with cytoskeletons, finely regulated internal and external molecules, and genetic material that determines ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results